Millions of vulnerable people will receive the COVID-19 booster vaccine starting next week as the government confirms that it has accepted final advice from the Independent Joint Commission on Vaccination and Immunization (JCVI). It’s a schedule.
The program will be expanded to the same priority group as before. This includes caregiver residents, medical and social care workers, people over the age of 50, people aged 16-49 years in underlying health at high risk of severe COVID-19, and adult caregivers. , And contact with an adult household of immunosuppressed individuals. It will be prioritized.
However, the program is flexible and allows anyone who is eligible to receive a booster 6 months after the second dose. This approach allows you to give boosters to more vulnerable people faster.
This move ensures that prophylactic vaccines are provided to people at highest risk of serious illness due to COVID-19 and will be maintained during the winter. Unvaccinated people accounted for about 99% of all COVID-19-related deaths in the UK in the first half of this year, according to data released yesterday by ONS. All four UK countries follow JCVI’s advice.
Sajid Javid, Minister of Health, said:
The deployment of our vaccine is astounding. It is important to do everything possible to extend the protection provided by the vaccine, especially for those most vulnerable to COVID-19, especially when heading for the fall and winter months. I today received advice from an independent JCVI expert to provide booster immune vaccines to those at greatest risk.
The booster program will start next week, thanks to the extensive preparation that the NHS has already made to enable the booster jab to be deployed as soon as possible.
We recommend that everyone who is eligible to receive the COVID-19 and flu vaccines as soon as possible take the strongest possible precautions during the winter. “
Vaccination will begin next week and the NHS will contact people directly to let them know when it’s time to get the booster vaccine.
JCVI also advises that influenza and COVID-19 vaccine can be co-administered. The NHS considers when it is appropriate to use co-administration to support the deployment of both programs, and when waiting for the delivery of one vaccine does not excessively delay the other. It is important to accept both vaccines when you receive them. Therefore, it is advisable to inoculate both vaccines as soon as possible, rather than waiting for the possibility of combining both vaccines.
According to the scientific evidence that both provide a strong booster response, people are offered either the full dose of the Pfizer / BioNTech vaccine or the half dose of the Moderna vaccine. It doesn’t matter which vaccine the individual has previously received.
If neither can be provided, such as those who are allergic to either vaccine, JCVI advises that the Oxford / AstraZeneca vaccine can be used for those who receive this vaccine in the first and second doses. The Oxford / AstraZeneca vaccine is safe and effective and has already saved thousands of lives in the UK and around the world.
The NHS England will soon outline the details of the deployment. The deployment plan will use the existing network implemented in the COVID-19 vaccination program. This includes:
- Local vaccination services coordinated by the primary care network and local pharmacies.When
- Vaccination centers across the country give people access to boosters regardless of where they live.
Following JCVI’s tentative advice, the NHS sent a letter to the provider on July 1 requesting them to begin preparing for a potential booster program. The local NHS organization has worked with local providers, local governments and regional teams during the summer to ensure that these preparations are made.
The NHS’s plans include ensuring that local pharmacies, vaccination centers, and general practice providing booster jabs are competent, and the NHS is a program to get the most out of the NHS Estate. And has a workforce to provide countermeasures.
Influenza vaccination remains a priority. Recommended by UK staff and vulnerable groups since the late 1960s, the estimated death toll in the UK for the five seasons from 2015 to 2020 exceeds 11,000 per year. In the winter of 2019/2020, 86% of influenza-related deaths were in people over the age of 65.
JCVI’s advice takes into account data from government-funded COV-Boost clinical trials, investigating the impact of booster vaccinations on people’s immune system and the co-administration of influenza and influenza. I am paying attention to ComFluCOV. COVID19 vaccine.
According to the latest data from Public Health England and the University of Cambridge, the vaccine saved more than 112,300 lives and prevented 143,600 hospitalizations and 24 million cases in the United Kingdom.
Yesterday, the government announced that it would give people aged 12 to 15 years in the UK a single dose of the Pfizer / BioNTech COVID-19 vaccine starting next week, following advice from four UK chief medical officers. Over four in five adults across the UK have been vaccinated with both the COVID-19 vaccine, and more than half of the ages 16 and 17 have already participated in the first jab.
A total of 44,108,746 people received two doses (89.2%) and 48,458,700 received one dose (81.2%).
https://industrialnews.co.uk/covid-19-booster-vaccine-to-be-offered-to-millions-of-vulnerable-people-from-next-week/?utm_source=rss&utm_medium=rss&utm_campaign=covid-19-booster-vaccine-to-be-offered-to-millions-of-vulnerable-people-from-next-week COVID-19 booster vaccine will be available to millions of vulnerable people starting next week